ASRS
CHRS icon

Arizona State Retirement System’s Coherus Oncology CHRS Stock Holding History

Arizona State Retirement System’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,802
Closed -$92.6K – 2130
2023
Q4 		$92.6K Buy
27,802
+3,602
+15% +$9.65K ﹤0.01% 2107
2023
Q3 		$90.5K Buy
24,200
+863
+4% +$3.99K ﹤0.01% 2089
2023
Q2 		$99.6K Buy
23,337
+5,308
+29% +$31.3K ﹤0.01% 2123
2023
Q1 		$123K Buy
18,029
+484
+3% +$3.76K ﹤0.01% 2075
2022
Q4 		$139K Buy
17,545
+713
+4% +$5.49K ﹤0.01% 2033
2022
Q3 		$162K Buy
16,832
+79
+0.5% +$799 ﹤0.01% 1965
2022
Q2 		$121K Buy
16,753
+148
+0.9% +$1.29K ﹤0.01% 2071
2022
Q1 		$214K Buy
16,605
+138
+0.8% +$1.75K ﹤0.01% 1983
2021
Q4 		$263K Sell
16,467
-40
-0.2% -$700 ﹤0.01% 1914
2021
Q3 		$265K Buy
16,507
+677
+4% +$9.92K ﹤0.01% 1910
2021
Q2 		$219K Sell
15,830
-949
-6% -$13.4K ﹤0.01% 2076
2021
Q1 		$245K Buy
16,779
+197
+1% +$3.35K ﹤0.01% 1930
2020
Q4 		$288K Sell
16,582
-536
-3% -$9.54K ﹤0.01% 1743
2020
Q3 		$314K Buy
17,118
+4,455
+35% +$82.9K ﹤0.01% 1570
2020
Q2 		$226K Buy
12,663
+315
+3% +$5.33K ﹤0.01% 1593
2020
Q1 		$200K Buy
+12,348
New +$228K ﹤0.01% 1512

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Arizona State Retirement System's CHRS Position: Q1 2024 in Review

Arizona State Retirement System sold out of Coherus Oncology (CHRS) in Q1 2024, closing a stake of 27,802 shares — an estimated $92.6K sold.

Arizona State Retirement System first reported a position in CHRS in Q1 2020 and held it in 16 quarters. The position peaked at $314K in Q3 2020. 137 funds tracked by Wall St. Rank hold CHRS as of Q1 2024.

  • Arizona State Retirement System reported no remaining Coherus Oncology position as of Q1 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 27,802 Coherus Oncology shares in Q1 2024, an estimated $92.6K.
  • Arizona State Retirement System first reported a position in Coherus Oncology in Q1 2020 and held it in 16 quarters.
  • Arizona State Retirement System's Coherus Oncology position peaked at $314K in Q3 2020.
  • 137 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2024.

Based on Arizona State Retirement System's 13F filing for Q1 2024, filed 7 May 2024.